[ALNY] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
23-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 48.88%
YoY- 19.72%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 750,530 318,754 319,290 335,035 264,306 224,818 213,259 131.19%
PBT 150,741 -274,209 -172,362 -207,021 -405,943 -274,673 -239,356 -
Tax 2,988 1,815 1,739 472 -23 2,729 985 109.41%
NP 147,753 -276,024 -174,101 -207,493 -405,920 -277,402 -240,341 -
Tax Rate -1.98% - - - - - - -
Total Cost 602,777 594,778 493,391 542,528 670,226 502,220 453,600 20.85%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 19.69 -86.59 -54.53 -61.93 -153.58 -123.39 -112.70 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS 1.18 -2.21 -1.40 -1.68 -3.32 -2.29 -2.00 -
EPS Diluted 1.15 -2.21 -1.40 -1.68 -3.32 -2.29 -2.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.